Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus fentanyl added to intrathecal ropivacaine for lower limb fracture surgery
IRCT20141209020258N115Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of dexmedetomidine, fentanyl and ropivacaine in femoral fracture (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: blood pressure, heart rate and 5 more. Started Apr 2019; status: completed.
02
Drugs
dexmedetomidinefentanylropivacaine
03
Conditions
femoral fracture
Beyond the preview
Go deeper on IRCT20141209020258N115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N115.